Abstract Abnormal expression of cyclin-dependent kinase 2 (CDK2)/cyclin-E is detected in colorectal, ovarian, breast and prostate cancers. The study of CDK2 with a bound inhibitor revealed CDK2 as a potential therapeutic target for several proliferative diseases. Several highly selective inhibitors of CDK2 are currently undergoing clinical trials, but possibilities remain for the identification and development of novel and improved inhibitors. For example, in silico targeting of ATP-competitive inhibitors of CDKs is of special interest. A series of 3,5-diaminoindazoles was studied using molecular docking and comparative field analyses. We used post-docking short time molecular dynamics (MD) simulation to account for receptor flexibility. The three types of structures, i.e., the highest energy, lowest energy and the structure most resembling the X-ray structure (three complexes) were identified for all ligands. QM/MM energy calculations were performed using a DFT b3lyp/6–31 g* and MM OPLS-2005 force field. Conceptual DFT properties such as the interaction energy of ligand to protein, global hardness (η), HOMO density, electrostatic potential, and electron density were calculated and related to inhibitory activity. CoMFA and CoMSIA were used to account for steric and electrostatic interactions. The results of this study provide insight into the bioactive conformation, interactions involved, and the effect of different drug fragments over different biological activities.
conformation        0.545274091715313^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Protein_structure     

electrostatic potential       0.9999983741051467^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrostatics        

CDK2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase_2

receptor                      0.9999999998922249^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Receptor_(biochemistry)

cyclin-dependent kinase       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase

breast                        0.9999999947367542^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Breast_cancer         

molecular docking             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Docking_(molecular)   

CDK2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase_2

HOMO                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/HOMO/LUMO             

inhibitor                     0.9926096797461779^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

DFT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Density_functional_theory

simulation                    0.9930885589399461^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computer_simulation   

force field                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Force_field_(chemistry)

CDKs                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase

electrostatic interactions    0.9948986852367373^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Intermolecular_force  

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

ligand                        0.9999719647476947^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand                

prostate cancers              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prostate_cancer       

QM/MM                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/QM/MM                 

ligands                       0.9999852954364284^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand                

MD                            0.7861232600896247^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Physician             

steric                        0.9999999994408881^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Steric_effects        

DFT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Density_functional_theory

clinical trials               0.9999999984186161^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Clinical_trial        

bioactive                     0.9997039339340725^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Biological_activity   

OPLS                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/OPLS                  

electron density              0.9999973434015645^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electron_density      

CDK2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase_2

X-ray structure               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/X-ray_crystallography 

CDK2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase_2

energy                        0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

energy                        0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

b3lyp                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hybrid_functional     

energy                        0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

energy                        0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

protein                       0.9999999885080798^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

MM                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_mechanics   

